Xencor GAAP EPS of -$0.09 beats by $0.50, revenue of $28.24M misses by $1.73M
Source: SeekingAlpha
2026-02-25 17:41:17 ET
More on Xencor
- Xencor: Fortress Balance Sheet Bodes Well For XmAb819 And XmAb942
- Incyte marks late-stage trial win for Xencor-partnered lymphoma therapy
- Incyte announces EU approval of Xencor-partnered lymphoma therapy
- Seeking Alpha’s Quant Rating on Xencor
- Historical earnings data for Xencor
Read the full article on Seeking Alpha
For further details see:
Xencor GAAP EPS of -$0.09 beats by $0.50, revenue of $28.24M misses by $1.73M
Xencor Inc.
NASDAQ: XNCR
XNCR Trading
6.59% G/L:
$11.645 Last:
241,674 Volume:
$11.25 Open:
XNCR Latest News
XNCR Stock Data
$902,628,328
68,011,331
N/A
68
N/A
Biotechnology & Life Sciences
Healthcare
US
Pasadena
